Pfizer Inc. closed 18.77% short of its 52-week high of $31.54, which the company achieved on July 30th.

Pfizer chief corporate affairs officer Sally Susman is departing the company after roughly two decades, CEO Albert Bourla ...

One of the best known communications executives in corporate America, Susman worked at Pfizer for nearly two decades after ...

According to Bloomberg, citing an email sent by Chief Executive Officer Albert Bourla on Tuesday, Susman’s responsibilities ...

Executive Vice President and Chief Corporate Affairs Officer, Sally Susman, is leaving after serving the company for 18 long ...

A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that there was a conspiracy among ...

Pfizer has been a big name in healthcare for decades, but it has been a largely underwhelming investment over the past 10 ...

The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...

At recent prices, the yield you receive from Pfizer is more than four times the amount you'd receive from the average ...

Pfizer recently announced positive results from the BASIS study, the global phase 3 trial evaluating Hympavzi in young adults ...

The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an ...

PFE's robust late-stage pipeline, recent FDA wins and deep oncology bets position it for long-term growth through 2030.